Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation

Description

The purpose of this study is to assess the effectiveness of prophylactic oxytocin on hemorrhage rates for second trimester dilation and evacuation (D\&E) in the clinic setting.

Conditions

Hemorrhage

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to assess the effectiveness of prophylactic oxytocin on hemorrhage rates for second trimester dilation and evacuation (D\&E) in the clinic setting.

Changes in Rate of Hemorrhage With Prophylactic Oxytocin for Second Trimester Dilation and Evacuation in the Clinic Setting

Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation

Condition
Hemorrhage
Intervention / Treatment

-

Contacts and Locations

Denver

Comprehensive Women's Health Center, Denver, Colorado, United States, 80230

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * clinic-based D\&E at 18 weeks gestational age and above
  • * speaks English or Spanish
  • * refuses IV
  • * history of coagulopathy
  • * anticoagulant use in the preceding five days
  • * chorioamnionitis or sepsis
  • * suspected placenta accreta spectrum
  • * intrauterine fetal demise
  • * multiple gestation
  • * use of misoprostol for cervical preparation

Ages Eligible for Study

18 Years to 55 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Colorado, Denver,

Study Record Dates

2026-11-02